A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 6, 2005, Pages 539-547

  Delbello, Melissa P ^a   Findling, Robert L ^b   Kushner, Stuart ^c   Wang, Daniel ^c   Olson, William H ^d   Capece, Julie A ^d   Fazzio, Lydia ^d   Rosenthal, Norman R ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Bipolar disorder; Mania; Topiramate

Indexed keywords

TOPIRAMATE;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ARTICLE; BIPOLAR I DISORDER; BIPOLAR MANIA; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE;

EID: 19344363150     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000159151.75345.20     Document Type: Article

References (41)

1. Brambilla P, Perez J, Barale F, Schettini G, Soares JC (2003), GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721-737
2. Calabrese JR, Keck PE Jr, McElroy SL, Shelton MD (2001), A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 21:340-342
3. Carlson GA, Jensen PS, Findling RL et al. (2003), Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol 13:13-27
4. Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG Jr (2003), Pharmacologic treatment of binge eating disorder. Int J Eat Disord 34(suppl):S74-S88
5. Chengappa KN, Chalasani L, Brar JS, Parepally H, Houck P, Levine J (2002), Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, non-randomized chart review. Clin Ther 24:1576-1584
6. Chengappa KN, Rathore D, Levine J et al. (1999), Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1:42-53
7. DelBello MP, Kowatch R, Warner J et al. (2003), Adjunctive topiramate in pediatric bipolar patients hospitalized for and acute manic or mixed episode. Presented at the American Academy of Child and Adolescent Psychiatry 50th Anniversary Meeting Miami
8. DelBello MP, Kowatch RA, Warner J et al. (2002a), Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review. J Child Adolesc Psychopharmacol 12:323-330
9. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM (2002b), A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223
10. Findling RL, Feeny NC, Stansbrey RJ, DelPorto-Bedoya D, Demeter C (2004), Somatic treatment for depressive illnesses in children and adolescents. Psychiatr Clin North Am 27:113-137
11. Findling RL, Gracious BL, McNamara NK et al. (2001), Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord 3:202-210
12. Fristad MA, Weller EB, Weller RA (1992), The Mania Rating Scale: can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 31:252-257
13. Geller B, Cooper TB, Sun K et al. (1998), Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37:171-178
14. Geller B, Craney JL, Bolhofner K et al. (2003), Phenomenology and longitudinal course of children with prepubertal and early adolescent bipolar disorder phenotype. In: Bipolar Disorder in Childhood and Early Adolescence, Geller B, DelBello MP, eds. New York: Guilford, pp 25-50
15. Grunze HC, Normann C, Langosch J et al. (2001), Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. J Clin Psychiatry 62:464-468
16. Guy W (1976), ECDEU Assessment Manual for Psychopharmacology. Rev. Rockville, MD: National Institute of Mental Health. Psychopharmacology Research Branch
17. Handbook of Psychiatric Measures (2000), Washington, DC: American Psychiatric Association, pp 540-542
18. Hazell P, O'Connell D, Heathcote D, Henry D (2002), Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. CD002317
19. Hoopes SP, Reimherr FW, Hedges DW et al. (2003), Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry 64:1335-1341
20. Hughes CW, Rintelmann J, Emslie GJ, Lopez M, MacCabe N (2001), A revised anchored version of the BPRS-C for childhood psychiatric disorders. J Child Adolesc Psychopharmacol 11:77-93
21. Jallon P, Picard F (2001), Bodyweight gain and anticonvulsants: a comparative review. Drug Saf 24:969-978
22. Johnson BA, Ait-Daoud N, Bowden CL et al. (2003), Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677-1685
23. Kaufman J, Birmaher B, Brent D et al. (1997), Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988
24. Levisohn PM (2000), Safety and tolerability of topiramate in children. J Child Neurol 15(suppl 1):S22-S26
25. McElroy SL, Arnold LM, Shapira NA et al. (2003), Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160:255-261
26. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH (2002), Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 75:978-985
27. Obrocea GV, Dunn RM, Frye MA et al. (2002), Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 51:253-260
28. Powers PS, Sachs GS, Kushner SF et al. (2004), Topiramate in adults with acute bipolar I mania: pooled results. Presented at the 157th Annual Meeting of the American Psychiatric Association, New York
29. Poznanski EO, Freeman LN, Mokros HB (1985), Children's Depression Rating Scale Revised. Psychopharmacol Bull 4:979-989
30. Ray JW, Shadish WR (1996), How interchangeable are different estimators of effect size? J Consult Clin Psychol 64:1316-1325
31. Rubio G, Ponce G, Jimenez-Arriero MA, Palomo T, Manzanares J, Ferre F (2004), Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 37:37-40
32. Sachs GS, Guille C (1999), Weight gain associated with use of psychotropic medications. J Clin Psychiatry 60(suppl 21):16-19
33. Sanacora G, Rothman DL, Mason G, Krystal JH (2003), Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 1003:292-308
34. Shaffer D, Gould MS, Brasic J et al. (1983), A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228-1231
35. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE (2000), An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41(suppl 1):S3-S9
36. Suppes T, Leverich GS, Keck PE et al. (2001), The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 67:45-59
37. White HS (2003), Mechanism of action of newer anticonvulsants. J Clin Psychiatry 64(suppl 8):5-8
38. World Medical Association (1964), Declaration of Helsinki: Ethical Principles for Research Involving Human Subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964; http.//www.wma.net/e/ policy/b3.htm (accessed September 2004)
39. Wozniak J, Biederman J, Richards JA (2001), Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder. J Clin Psychiatry 62(suppl 14):10-15
40. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978), A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435
41. Youngstrom EA, Danielson CK, Findling RL, Gracious BL, Calabrese JR (2002), Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol 31:567-572